Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2023-01-09 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于使用闲置自有资金进行现金管理的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company (葵花药业集团股份有限公司) regarding the progress of using idle self-owned funds for cash management. It details the amounts invested, types of financial products purchased, risk control measures, and the impact on the company. The document is structured as a formal announcement with tables of investments and risk disclosures. It does not contain comprehensive financial statements or detailed financial performance data typical of an Annual Report (10-K) or Interim Report (IR). It is not a call transcript, management report, or earnings release. The document is a regulatory announcement about the company's cash management activities and investment progress, which fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other more specific categories.
2023-01-09 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company (葵花药业集团股份有限公司) regarding the progress of using idle self-owned funds for cash management. It details the amounts invested, types of financial products purchased, risk control measures, and the impact on the company. The document is structured as a formal announcement with tables of investment details and risk disclosures. It does not contain comprehensive financial statements or detailed financial performance data typical of an Annual Report or Interim Report. It is not a report publication announcement since it contains substantive information about the cash management activities and their progress, not just a notice of report availability. The content fits best with a Capital/Financing Update (CAP) as it relates to the company's financing activities and cash management updates. Therefore, the appropriate classification is CAP with high confidence.
2022-12-30 Chinese
2022年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions passed at the 2022 third extraordinary general meeting of shareholders of the company. It details the meeting date, voting procedures, attendance, voting results on proposals, and legal opinions from lawyers witnessing the meeting. There is no financial data or report content, only the official voting results and procedural information. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2061 characters) and it is clearly a voting results announcement rather than a full report or presentation.
2022-11-29 Chinese
葵花药业2022年第三次临时股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the convening, procedures, attendance, and voting results of a specific shareholders' meeting (the 2022 third extraordinary general meeting) of a company. It details the legality and validity of the meeting's call, attendance, and voting process, and confirms the results of the shareholder vote. It does not contain financial statements or performance data, nor is it a report of financial results or management discussion. It is a legal opinion related to a shareholders' meeting and the voting process, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is under 5,000 characters and is a formal legal opinion accompanying the voting results, not the full AGM materials or presentations. Therefore, the best classification is DVA.
2022-11-29 Chinese
关于高级管理人员退休的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the retirement of a senior management personnel, specifically the vice general manager who has reached the statutory retirement age and completed retirement procedures. It discusses changes in senior management roles but does not contain financial data, audit information, or other report content. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2022-11-29 Chinese
关于公司实际控制人减持公司股份预披露公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding the planned reduction of shares held by the company's actual controller, including details about the number of shares, timing, methods of sale, and compliance with regulatory requirements. It is a disclosure about insider shareholding changes rather than a financial report, earnings release, or management discussion. The content fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. The document length is short and focused on shareholding changes, not a full report or announcement of a report publication.
2022-11-25 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.